Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05675995 · ClinicalTrials.gov registry record · NA

Qigong for Post Acute Sequelae of COVID-19 Infection

A NA study of Long COVID, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05675995: Completed NA study of Long COVID, sponsored by University of California, Davis.

NCT05675995 is a NA study of Long COVID that has completed, run by University of California, Davis. The registered enrollment target is 40 participants, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05675995, a NA study of Long COVID, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct a pilot feasibility study of a combination of external and internal qigong on health-related quality of life in individuals with prolonged symptoms following COVID-19 infection.

Primary Outcome

Changes in PROMIS-29 summary scores from before to after intervention in all participants

Conditions Studied

Interventions

  • BEHAVIORAL Qigong

Study Locations (1)

California

  • University of California Davis Health - Sacramento

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-01-04
Est. Completion 2024-05-15
Phase NA
University of California, Davis

657 total trials

What the finished NCT05675995 record still lists

NCT05675995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Qigong is the first listed.

NCT05675995 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05675995 about?

NCT05675995 is a clinical study titled "Qigong for Post Acute Sequelae of COVID-19 Infection". The purpose of this study is to conduct a pilot feasibility study of a combination of external and internal qigong on health-related quality of life in individuals with prolonged symptoms following COVID-19 infection.

What is the current status of trial NCT05675995?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-01-04. Estimated completion is 2024-05-15.

What conditions does trial NCT05675995 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT05675995?

The interventions under investigation include: Qigong (BEHAVIORAL).

Who is sponsoring clinical trial NCT05675995?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05675995 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05675995's enrollment target sits among peer trials

40 38th of 50 higher than 11 of 50 other Long COVID trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05675995, the US trial registry maintained by the National Library of Medicine. NCT05675995 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.